What is continuous glucose monitoring system (CGMS)?
A Continuous Glucose Monitoring System (CGMS) is a medical device that tracks glucose levels in real time through a small wearable sensor placed under the skin. Unlike traditional fingerprick testing, which provides a single glucose reading at one moment, CGMS offers continuous data, showing trends, patterns, and alerts for high or low glucose levels —helping healthcare providers and patients make more informed, proactive treatment decisions.
How does CGMS work?
- Once the CGM is applied to your arm, the sensor begins working beneath the skin.
- The sensor contains biomaterials that react with glucose in the interstitial fluid. These reactions generate biochemical signals, which are detected and converted into glucose values every few minutes.
- The transmitter then sends this data to your phone app or receiver.
- Allowing you to view glucose trends, receive high and low alerts, and monitor changes throughout the day.
Note: Since glucose naturally moves from the bloodstream into the interstitial fluid, interstitial glucose readings closely reflect blood glucose levels.
Continuous glucose monitoring VERSUS Traditional glucose testing
| What you get | CGMS | Traditional glucose testing |
|---|---|---|
| Glucose values | ✓ Real-time glucose values | ✗ Single-point measurements |
| Trends | ✓ Glucose trends | ✗ Isolated glucose readings |
| Alerts | ✓ High & low glucose alerts | ✗ Manual checking |
| Prevention | ✓ Predictive alerts & prevention | ✗ Delayed symptom-based response |
| Monitoring cadence | ✓ Continuous monitoring | ✗ Periodic testing |
| Data history | ✓ Long-term data visibility | ✗ Limited history |
| Where care happens | ✓ Remote patient monitoring | ✗ In-clinic tracking |
| Treatment decisions | ✓ Data-driven treatment decisions | ✗ Snapshot-based medical decisions |
| The record you keep | ✓ Continuous glucose history | ✗ Individual test results |
Market signals driving CGM growth
The global diabetes epidemic and rising healthcare expenditure are accelerating demand for continuous monitoring solutions.
Adults worldwide living with diabetes
The number of adults living with diabetes has more than tripled since 2000, driven by aging populations, rising obesity rates, and increasingly sedentary lifestyles across both developed and developing nations.
Annual global diabetes healthcare expenditure
Diabetes accounts for a significant and growing share of global healthcare spending, covering medications, devices, hospitalizations, and long-term complication management across all regions.
Projected adults with diabetes by 2050
Without significant intervention, the number of adults with diabetes is projected to continue rising sharply, creating sustained long-term demand for advanced monitoring and management tools.
Global CGM market size in 2025
The CGM devices market reached an estimated USD 13.38 billion in 2025, with the US alone accounting for USD 5.6 billion, driven by strong reimbursement policies and growing Type 2 diabetes adoption.
CAGR forecast 2026–2035
The CGM market is projected to grow at a compound annual growth rate of 16.3% from 2026 to 2035, outpacing most other medical device segments and reflecting accelerating global adoption.
Projected CGM market size by 2033
The global CGM devices market is forecast to nearly triple from 2025 levels, reaching USD 41.41 billion by 2033 as non-invasive technologies and AI-powered analytics drive next-generation adoption.
Diabetes patients not achieving glycemic targets
Despite advances in treatment, only about half of individuals with diabetes achieve recommended glycemic targets —highlighting the urgent need for better continuous monitoring solutions.
Global diabetes prevalence growth rate
Diabetes prevalence continues to rise at approximately 4.2% annually in developing regions, driven by urbanization, dietary changes, and aging populations —expanding the addressable CGM market.
Are CGMS worth it for healthcare providers?
Adding CGM to your healthcare portfolio creates clinical and commercial value across multiple dimensions.
Retain market share
As CGM adoption grows, offering CGM solutions helps your business stay competitive in an evolving diabetes care market and meet changing customer expectations.
Expand product category
Add CGM to your existing diabetes, diagnostic, or chronic care portfolio, creating extra value for clients and new opportunities for growth.
Grow revenue
CGM systems rely on disposable sensors that are typically replaced every 14 days, allowing you to benefit from continuous repeat orders rather than one-time purchases.
Improve patient treatment
CGM gives you trend-based glucose insights instead of isolated measurements, helping doctors and healthcare teams make informed treatment decisions.
Improve clinical efficiency
You can reduce reliance on scattered glucose checks and integrate continuous glucose data into digital health workflows, improving patient monitoring beyond in-person visits.
Support preventive monitoring
CGM allows care teams to monitor patients' glucose changes continuously, helping identify abnormal patterns before they become more serious.
How to build your CGM business in no time?
Choose the partnership model that fits your business stage and capabilities.
CGM SKD (Semi-Knocked Down)
Partially assembled CGM kits that allow you to complete local assembly, packaging, and labeling under your own brand. Includes regulatory documentation support to help you navigate country-specific compliance requirements.
CGM OEM (Original Equipment Manufacturing)
Launch your own branded CGM with full system manufacturing handled by EverChek. From sensor production to final packaging, we build the complete product to your specifications while you focus on market development.
CGM distribution
Become an authorized distributor of EverChek CGM products in your region. No assembly lines or clean rooms needed —simply leverage our ready-to-market products and your local sales network.
Why work with us?
EverChek brings end-to-end CGM expertise — from R&D to regulatory compliance — to accelerate your market entry.
In-house CGM development
We develop our CGM technology in-house—from sensor design to algorithms and full system integration. This gives you direct technical support, better product control, and a more stable supply chain.
Manufacturing capability
Our production facilities are built for scalable manufacturing with consistent quality standards. You get reliable supply, predictable lead times, and stable product performance.
Dedicated software ecosystem
Beyond hardware, we provide both patient and physician applications. You offer a complete CGM solution with connected data, monitoring, and clinical visibility.
Regulatory support
We support partners with registration preparation, technical documentation, and compliance requirements to simplify local market entry.
Flexible cooperation models
Whether you need SKD, OEM, distribution, or a customized partnership structure, we adapt based on your market goals, regulatory needs, and business stage.
Built for long-term partnership
We work as a long-term partner, supporting your growth as your business expands into new markets and larger opportunities.
Your long-term B2B CGM manufacturing partner
We combine self-developed CGM technologies with scalable manufacturing infrastructure to support healthcare brands worldwide.